Tate & Lyle’s (TATE) “Neutral” Rating Reaffirmed at UBS Group

Tate & Lyle (LON:TATE)‘s stock had its “neutral” rating restated by stock analysts at UBS Group in a report released on Monday,Digital Look reports. They currently have a GBX 375 price objective on the stock. UBS Group’s target price suggests a potential downside of 29.64% from the company’s previous close.

Separately, Deutsche Bank Aktiengesellschaft raised shares of Tate & Lyle to a “buy” rating and raised their price target for the stock from GBX 460 to GBX 595 in a research note on Friday. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of GBX 490.

Tate & Lyle Stock Down 1.4%

TATE opened at GBX 533 on Monday. The firm has a market cap of £2.35 billion, a P/E ratio of 95.18, a PEG ratio of 1.37 and a beta of 0.28. The business’s fifty day simple moving average is GBX 360.81 and its 200 day simple moving average is GBX 372.47. Tate & Lyle has a 52 week low of GBX 319.40 and a 52 week high of GBX 610. The company has a quick ratio of 1.77, a current ratio of 2.19 and a debt-to-equity ratio of 83.31.

About Tate & Lyle

Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers dairy products, soups, sauces, and dressings; bakery products and snacks; texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; fibres; and stabilizers and functional systems.